EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

$7.67
-0.52 (-6.35%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +293.0% upside
Low Target $22.58
Average Target $30.14
High Target $41.69
Current Price $7.67
Current
$7.67
Target
$30.14
$22.58 $30.14 avg $41.69
Scenario Analysis
Bear Case
$22.58
194.4%
Low target
Base Case
$30.14
+293.0%
Avg target
Bull Case
$41.69
+443.5%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$20.32
-62.3% from high
52-Week Low
$0.72
+965.3% from low
Target vs 52W High
$30.14
+48.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.2%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.6%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.0%